NUTM1 and nut midline carcinoma: Currently, the diagnosis of NMC depends on the identification of a rearrangement involving the NUT locus at 15q14 that generates a specific fusion transcript with a member of the bromodomain-containing protein (BRD) family, such as BRD4 located on chromosome 19p13.1.